咨询与建议

看过本文的还看了

相关文献

该作者的其他文献

文献详情 >Alternative Phenotypic Profile... 收藏

Alternative Phenotypic Profile for B-Cell Abnormality in a Case at Zinder National Hospital

Alternative Phenotypic Profile for B-Cell Abnormality in a Case at Zinder National Hospital

作     者:Brah Moustapha Maman Amadou Djibrilla-Almoustapha Moustapha Elhadji-Chefou Abdoul-Aziz Garba Badé Malam-Abdou Brah Moustapha Maman;Amadou Djibrilla-Almoustapha;Moustapha Elhadji-Chefou;Abdoul-Aziz Garba;Badé Malam-Abdou

作者机构:Department of Medicine Université André Salifou de Zinder Zinder Niger Department of Medicine Hôpital National de Zinder Zinder Niger Department of Medicine Université Abdou Moumouni de Niamey Niamey Niger Department of Medicine Université Dan Dicko Dan Koulodo de Maradi Maradi Niger 

出 版 物:《Open Journal of Blood Diseases》 (血液病期刊(英文))

年 卷 期:2024年第14卷第1期

页      面:8-16页

学科分类:1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学] 

主  题:Hyperlymphocytosis CLL Immunophenotyping MINICHOP 

摘      要:Introduction: Since it is impossible to establish a diagnosis in the presence of hyperlymphocytosis not secondary to lymphocytic hyperactivation, we considered a B-lymphoid hematopathy with a non-specific phenotypic profile. We report one case of this. Observation: This is a forty-eight (48) year old patient with hyperlymphocytosis at 139,000 elements per cubic millimeter, heterogeneous splenomegaly at 25.6 cm in diameter on abdominal ultrasound without detectable deep or peripheral lymphadenopathy. Peripheral blood cytology shows lymphocyte cell proliferation suggestive of the circulating phase of chronic lymphoproliferative B syndrome. The expression profile of cell membrane markers did not allow for the definition of a specific phenotypic profile. Faced with this immunophenotyping result, we considered a B-lymphoid hemopathy with a non-specific phenotypic profile. After three courses, the MINICHOP treatment was used to achieve partial remission with wasting of more than 80% of the evaluable masses. Conclusion: Despite the contribution of immunophenotyping in the diagnosis of lymphoproliferative syndromes, it is possible to consider the diagnosis of a B-lymphoid hemopathy with a phenotypic non-specific profile of CD45+, monotypic kappa, CD19+, FMC7+, CD22+, CD5−, CD79b−, CD23−, CD43−, CD38−, CD200−.

读者评论 与其他读者分享你的观点

用户名:未登录
我的评分